Page 2 - Erik Manting News Today

Press Release Stockholm, Sweden, December 5, 2023 Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced it will present the...

Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13...

Press Release Stockholm, Sweden, November 3, 2023 Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in peer-reviewed medical journal Publication...

Press Release Stockholm, Sweden, November 3, 2023 Mendus Phase 1 vididencel clinical trial results in AML and high-risk MDS patients published in...

Press Release Stockholm, Sweden, November 2, 2023   Mendus announces multiple abstracts to be presented at ASH 2023 including oral presentation on ADVANCE II survival data Three abstracts...

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: LSX...

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, will present novel clinical and preclinical data on the mode of action of its lead clinical program...

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that it has received Fast Track Designation from the U.S. Food and Drug Administration ...

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company will present a company presentation and participate in one-on-one...

Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the following upcoming investor and industry conferences: H.C. Wainwright 25th Annual Global Investment Conference New York, USA, September 11-13, 2023 Mendus CEO Erik Manting will participate and present a Company Update at the conference: https://hcwevents.com/annualconference/ Pareto Securities' Annual Healthcare Confer...